A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
PHASE3
A study to evaluate cadonilimab (AK104) + lenvatinib in combination with tr...